Page last updated: 2024-10-30

manidipine and Bright Disease

manidipine has been researched along with Bright Disease in 1 studies

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research Excerpts

ExcerptRelevanceReference
"We evaluated the effects of a novel calcium antagonist, manidipine, on albuminuria in rats with passive Heymann nephritis (PHN)."7.69Reduction of albuminuria by a calcium antagonist, manidipine, in rats with passive Heymann nephritis. ( Arai, T; Hishida, A; Kobayashi, S; Nakajima, T, 1994)
"We evaluated the effects of a novel calcium antagonist, manidipine, on albuminuria in rats with passive Heymann nephritis (PHN)."3.69Reduction of albuminuria by a calcium antagonist, manidipine, in rats with passive Heymann nephritis. ( Arai, T; Hishida, A; Kobayashi, S; Nakajima, T, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, T1
Kobayashi, S1
Nakajima, T1
Hishida, A1

Other Studies

1 other study available for manidipine and Bright Disease

ArticleYear
Reduction of albuminuria by a calcium antagonist, manidipine, in rats with passive Heymann nephritis.
    Nihon Jinzo Gakkai shi, 1994, Volume: 36, Issue:11

    Topics: Albuminuria; Animals; Calcium Channel Blockers; Creatinine; Dihydropyridines; Glomerulonephritis; Ki

1994